Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Biota Pharmaceuticals
|
| gptkbp:acquisitionYear |
2012
|
| gptkbp:focus |
gptkb:immunotherapy
infectious diseases addiction treatments |
| gptkbp:formerName |
Nabi, Inc.
|
| gptkbp:founded |
1966
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
NicVAX
|
| gptkbp:status |
defunct
|
| gptkbp:tradedOn |
NASDAQ:NABI
|
| gptkbp:bfsParent |
gptkb:Nabi-HB
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nabi Biopharmaceuticals
|